Therapeutic Potential of Human Adipose Stem Cells in a Rat Myocardial Infarction Model
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Stem cell transplantation is expected to have good effects in the treatment of myocardial infarction (MI). We tested the effect of the transplantation of human adipose-derived cells (ASCs) in Sprague-Dawley (SD) rats with myocardial infarctions. Materials and Methods: ASCs were isolated from the waste of elective abdominal surgery. The MI model was set up in SD rats by permanent ligation of the left anterior descending coronary artery. One week after MI, either 1 x 106 ASCs or an equal volume of phosphate-buffered saline (PBS) was injected into the infarct zone. Cardiac function was assessed by echocardiography, 1 day, 1 week, 2 weeks, and 4 weeks after treatment. Four weeks after transplantation, immunohistochemistry was performed. Results: Left ventricular function, including fractional shortening (FS), and ejection fraction (EF) showed a significant improvement in the ASCs transplantation group compared to the PBS group 4 weeks after treatment (p < 0.05). The anterior wall thickness of the left ventricle was significantly thicker in the ASCs transplantation group compared to the PBS group (p < 0.01). Multiple troponin T staining, and irregular, small amounts of connexin 43 expression also was observed in the ASCs transplantation group. Infarcted myocardium showed higher capillary density in the ASCs transplantation group than in the PBS injected group (p < 0.01). Conclusion: This study provides encouraging evidence that transplantation of ASCs can improve cardiac function of infarct myocardium in rat models with a limitation of cardiac remodeling, improved wall thickness, and increased neovascularization.
Abstract
Purpose: Stem cell transplantation is expected to have good effects in the treatment of myocardial infarction (MI). We tested the effect of the transplantation of human adipose-derived cells (ASCs) in Sprague-Dawley (SD) rats with myocardial infarctions. Materials and Methods: ASCs were isolated from the waste of elective abdominal surgery. The MI model was set up in SD rats by permanent ligation of the left anterior descending coronary artery. One week after MI, either 1 x 106 ASCs or an equal volume of phosphate-buffered saline (PBS) was injected into the infarct zone. Cardiac function was assessed by echocardiography, 1 day, 1 week, 2 weeks, and 4 weeks after treatment. Four weeks after transplantation, immunohistochemistry was performed. Results: Left ventricular function, including fractional shortening (FS), and ejection fraction (EF) showed a significant improvement in the ASCs transplantation group compared to the PBS group 4 weeks after treatment (p < 0.05). The anterior wall thickness of the left ventricle was significantly thicker in the ASCs transplantation group compared to the PBS group (p < 0.01). Multiple troponin T staining, and irregular, small amounts of connexin 43 expression also was observed in the ASCs transplantation group. Infarcted myocardium showed higher capillary density in the ASCs transplantation group than in the PBS injected group (p < 0.01). Conclusion: This study provides encouraging evidence that transplantation of ASCs can improve cardiac function of infarct myocardium in rat models with a limitation of cardiac remodeling, improved wall thickness, and increased neovascularization.
참고문헌 (40)
- Dimmeler S, "Wanted! The best cell for cardiac regeneration", J Am Coll Cardiol, 44, pp.464~466 (2004)
- Dimmeler S, "Unchain my heart:scientific foundations of cardiac repair", J Clin Invest, 115, pp.572~583 (2005)
- Laflamme MA, "Regenerating the heart", Nat Biotechnol, 23, pp.845~856 (2005)
- Lee RH, "Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue", Cell Physiol Biochem, 14, pp.311~324 (2004)
- Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
- Vats A, "Stem cells", Lancet, 366, pp.592~602 (2005)
- Fraser JK, "Fat tissue: an underappreciated source of stem cells for biotechnology", Trends Biotechnol, 24, pp.150~154 (2006)
- Caplan AI, "Review: mesenchymal stem cells: cell-based reconstruction therapy in orthopedics", Tissue Eng, 11, pp.1198~1211 (2005)
- Zuk PA, "Human adipose tissue in a source of multipotent stem cells", Mol Biol Cell, 13, pp.4279~4295 (2002)
- Oedayrajsingh-Varma MJ, "Adipose tissuederived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure", Cytotheraphy, 8, pp.166~177 (2006)
- Prunet-Marcassus B, "From heterogeneity to plasticity in adipose tissues:site-specific differences", Exp Cell Res, 312, pp.727~736 (2006)
- Zuk PA, "Multilineage cells from human adipose tissue: implications of cell-based therapies", Tissue Eng, 7, pp.211~228 (2001)
- Trischmann TM, "Measurement of CD34+ cells in bone marrow by flow cytometry", J Hematother, 2, pp.305~313 (1993)
- Davani S, "Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model", Circulation, 108, pp.253~258 (2003)
- Jensen-Urstad K, "Comparison of different ehocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy", Am J Cardiol, 81, pp.538~544 (1998)
- Assmus B, "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI)", Circulation, 106, pp.3009~3017 (2002)
- Britten MB, "Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrastenhanced magnetic resonance imaging", Circulation, 108, pp.2212~2218 (2003)
- Kawada H, "Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction", Blood, 104, pp.3581~3587 (2004)
- Murry CE, "Haematopoietic stem cells do not transdifferentiate into cardiac myocysts in myocardial infarcts", Nature, 428, pp.664~668 (2004)
- Balsam LB, "Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium", Nature, 428, pp.668~673 (2004)
- Menasché P, "Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction", J Am Coll Cardiol, 41, pp.1078~1083 (2003)
- Hagége AA, "Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy", Lancet, 361, pp.491~492 (2003)
- Fernandes S, "Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias", Cardiovasc Res, 69, pp.348~358 (2006)
- Yamada Y, "Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes", Stem Cells, 25, pp.1326~1333 (2007)
- Asahara T, "Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization", Circ Res, 85, pp.221~228 (1999)
- Itescu S, "Myocardial neovascularization by adult bone marrow-derived angioblast: strategies for improvement of cardiomyocyte function", Heart fail revi, 8, pp.253~258 (2003)
- Orlic D, "Bone marrow cells regenerate infracted myocardium", Nature, 410, pp.701~705 (2001)
- Kajstura J, "Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion", Circ Res, 96, pp.127~137 (2005)
- Jackson KA, "Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells", J Clin Invest, 107, pp.1395~1402 (2001)
- Miranville A, "Improvement of postnatal neovascularization by human adipose tissue-derived stem cells", Circulation, 110, pp.349~355 (2004)
- Rehman J, "Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells", Circulation, 109, pp.1292~1298 (2004)
- Planat-Bénard V, "Spontaneous cardiomyocyst differentiation from adipose tissue stroma cells", Circ Res, 94, pp.223~229 (2004)
- Strem BM, "Expression of cardiomyocytic markers on adipose tissuederived cells in a murine model of acute myocardial injury", Cytotherapy, 7, pp.282~291 (2005)
- Yoon YP, "Unexpected severe calcification after transplantation after transplantation of bone marrow cells in acute myocardial infarction", Circulation, 109, pp.3154~3157 (2004)
- Dow J, "Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy", Cardiovasc Res, 67, pp.301~307 (2005)
- Reinecke H, "Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts", Circulation, 100, pp.193~202 (1999)
- Li RK, "Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury", Ann Thorac Surg, 72, pp.1957~1963 (2001)
- Potapova I, "Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers", Circ Res, 94, pp.952~959 (2004)
- Kraitchman DL, "In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction", Circulation, 107, pp.2290~2293 (2003)
- Barbash IM, "Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution", Circulation, 108, pp.863~868 (2003)